| This week's sponsor is Premier Research. | | | Taking the Fight to Rare Cancers
Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for biotech. |
Editor’s Note: We're off on Monday so we'll see you back here Tuesday. Have a great Labor Day! Today's Rundown AstraZeneca spinout Viela lines up $150M IPO to fund scrap with Alexion MGB tops up cash pool to wrap up antibiotic phase 2a Young startups on new-look Hong Kong exchange see major CEO pay packets EuroBiotech Report—Celgene-Immatics, AstraZeneca, Immunicum, Adaptimmune and InDex FiercePharmaAsia—HiFiBiO's Kite-backed C round; Kyowa Kirin's Parkinson's nod; Relief for Sun Chutes & Ladders—Boehringer Ingelheim shuffles exec team on heels of pipeline pickups
Featured Story | | | Friday, August 30, 2019 AstraZeneca spinout Viela Bio has filed to raise $150 million in an IPO. The listing would set Viela up to challenge Alexion and Roche for the neuromyelitis optica spectrum disorder market by giving it the means to advance anti-CD19 antibody inebilizumab. |
|
|---|
|
Top Stories Friday, August 30, 2019 MGB Biopharma has raised money to finish a phase 2a trial of its lead antibiotic MGB-BP-3 in people with Clostridium difficile-associated diarrhea. The small financing positions MGB to generate clinical data and prepare for next steps. Friday, August 30, 2019 We’re all used to seeing Big Pharma CEOs take home the biggest pay packets, but after a relaxing of listing rules in Hong Kong, we’re seeing some very early-stage biotechs handing out some major and even comparable checks to their leaders. Thursday, August 29, 2019 In this week's EuroBiotech Report, Celgene inks T-cell deal, AstraZeneca buys priority review voucher and Immunicum struggles against Pfizer drug. Friday, August 30, 2019 Immunotherapy-focused HiFiBiO Therapeutics raised $67 million in series C. Kyowa Kirin won an FDA go-ahead for Parkinson's add-on therapy Nourianz. A probe at India's securities agency reportedly cleared Sun Pharma of alleged violations. And more. Friday, August 30, 2019 Boehringer Ingelheim shuffles board, senior management; Medtronic CEO Ishrak set to retire in 2020; Zealand appoints Dallas to CFO role. | This week's sponsor is ExL Events. | | |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer
BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: Alexander Group
From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Wesco Pharmaceutical Solutions and WBR Insights
The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D. Sponsored by: Kinaxis
Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Patheon, by Thermo Fisher Scientific
Patheon, part of Thermo Fisher Scientific, offers advanced API manufacturing technologies such as continuous processing and continuous analytics to deliver high-quality products with well-defined features to meet your timelines and volume requirements. Sponsored by: ICON
Understanding the challenges for formulary decision makers and manufacturers. Sponsored by: Veeva
This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money. Sponsored by: Catalent
Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent
Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent
Download the eBook to explore a proactive approach for clinical supply management.
Latin America Healthcare Compliance Certificate Program September 23-26, 2019 BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 